We are live on ! Find out more
CF

CNA Financial Portfolio holdings

AUM $235M
1-Year Est. Return 3.39%
This Fund
S&P 500
This Quarter Est. Return
-6.57%
1 Year Est. Return
+3.39%
3 Year Est. Return
+50.54%
5 Year Est. Return
+66.93%
10 Year Est. Return
+254.04%
AUM
$322M
AUM Growth
-$60.2M
Cap. Flow
-$22.2M
Cap. Flow %
-6.9%
Top 10 Hldgs %
31.34%
Holding
203
New
11
Increased
51
Reduced
71
Closed
16

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$6.75M
2
LNG icon
Cheniere Energy
LNG
+$6.08M
3
HBI
Hanesbrands
HBI
+$4.72M
4
META icon
Meta Platforms (Facebook)
META
+$4.5M
5
GM icon
General Motors
GM
+$4.49M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$8.86M
2
CSGP icon
CoStar Group
CSGP
+$7.11M
3
CME icon
CME Group
CME
+$6.17M
4
J icon
Jacobs Solutions
J
+$5.57M
5
JPM icon
JPMorgan Chase
JPM
+$4.75M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 19.56%
3 Consumer Discretionary 14.54%
4 Industrials 8.94%
5 Financials 8.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TPTX
176
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$252K 0.08%
9,403
+320
+4% +$10.8K
TIL icon
177
Instil Bio
TIL
$49M
$244K 0.08%
1,134
– –
ADCT icon
178
ADC Therapeutics
ADCT
$140M
$228K 0.07%
15,515
+270
+2% +$4.29K
RXRX icon
179
Recursion Pharmaceuticals
RXRX
$1.58B
$205K 0.06%
28,672
+2,890
+11% +$30.7K
JAMF
180
DELISTED
Jamf
JAMF
$203K 0.06%
5,837
– –
PRAX icon
181
Praxis Precision Medicines
PRAX
$8.11B
$191K 0.06%
1,249
+34
+3% +$6.98K
SGHT icon
182
Sight Sciences
SGHT
$291M
$189K 0.06%
16,383
+2,356
+17% +$36.3K
ERAS icon
183
Erasca
ERAS
$6.15B
$147K 0.05%
17,077
– –
SHCO
184
DELISTED
Soho House & Co
SHCO
$114K 0.04%
14,684
-13,603
-48% -$120K
PAYA
185
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
$67K 0.02%
11,434
-49,020
-81% -$296K
ANNX icon
186
Annexon
ANNX
$796M
$64K 0.02%
23,423
+3,713
+19% +$22.8K
XWEL icon
187
XWELL
XWEL
$8.95M
$35K 0.01%
1,568
– –
AMPL icon
188
Amplitude
AMPL
$1.18B
– –
-11,213
Closed -$594K
BTAI icon
189
BioXcel Therapeutics
BTAI
$24.8M
– –
-897
Closed -$292K
CMCSA icon
190
Comcast
CMCSA
$87.3B
– –
-80,000
Closed -$4.03M
CME icon
191
CME Group
CME
$95.4B
– –
-27,000
Closed -$6.17M
CSGP icon
192
CoStar Group
CSGP
$12.2B
– –
-90,000
Closed -$7.11M
CYRX icon
193
CryoPort
CYRX
$753M
– –
-4,313
Closed -$255K
GH icon
194
Guardant Health
GH
$19.1B
– –
-2,928
Closed -$293K
HYFM icon
195
Hydrofarm Holdings
HYFM
$2.66M
– –
-1,766
Closed -$500K
J icon
196
Jacobs Solutions
J
$16B
– –
-48,359
Closed -$5.57M
JPM icon
197
JPMorgan Chase
JPM
$916B
– –
-30,000
Closed -$4.75M
PFE icon
198
Pfizer
PFE
$143B
– –
-150,000
Closed -$8.86M
RSKD icon
199
Riskified
RSKD
$719M
– –
-23,216
Closed -$182K
TWST icon
200
Twist Bioscience
TWST
$5.32B
– –
-3,879
Closed -$300K
5 6 7
8
9

Similar funds

JRPCML
J. R. Prunier Capital Management LLC Holden, Massachusetts $235M AUM
CWL
Causey Wealth LLC Greenwood Village, Colorado $236M AUM 14.5% 1-Year Est. Return
MC
Matisse Capital Portland, Oregon $234M AUM 19.72% 1-Year Est. Return
BWM
Bernard Wealth Management Royal Oak, Michigan $234M AUM 27.82% 1-Year Est. Return
GCM
Gables Capital Management Miami, Florida $236M AUM 32.91% 1-Year Est. Return
RP
Raelipskie Partnership Waterloo, Ontario, Canada $236M AUM 19.33% 1-Year Est. Return
KTM
Keeler Thomas Management Orem, Utah $236M AUM 10.79% 1-Year Est. Return
HWMT
Heritage Wealth Management (Texas) Houston, Texas $234M AUM 15.67% 1-Year Est. Return

CNA Financial's Q1 2022 Portfolio in Review

As of Q1 2022, CNA Financial held 203 positions worth $322M, down 16% from $383M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

CNA Financial withdrew a net $22.2M in Q1 2022, closing 16 positions and reducing 71 holdings. Its most notable exit was Pfizer, an estimated $8.86M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, CNA Financial opened a new position in Morgan Stanley worth $6.12M.

  • CNA Financial's largest Q1 2022 buy was Morgan Stanley: 70,000 shares worth $6.12M.
  • CNA Financial added most to Meta Platforms (Facebook) in Q1 2022, an estimated $4.5M increase.
  • CNA Financial's biggest Q1 2022 reduction was CVS Health, cutting an estimated $3.68M.
  • CNA Financial fully exited Pfizer in Q1 2022, selling an estimated $8.86M.
  • CNA Financial's ten largest holdings make up 31% of its $322M portfolio in Q1 2022.
  • CNA Financial opened 11 new positions and closed 16 in Q1 2022.
  • CNA Financial's portfolio value fell 16% quarter-over-quarter to $322M.

Based on CNA Financial's 13F filing for Q1 2022, filed 10 May 2022.